Skip to main content
Incyte8-K: Acquisition completed

Incyte Recognizes $1.23 Billion IPR&D Expense from Completed Acquisition of Vega Therapeutics

Source: Autobound Signal API · 75 signals tracked for Incyte · updated

Get Incyte's live signals in Claude or ChatGPT, or by API

AskWhat changed at Incyte this week? Use Autobound signals for incyte.com.

What happened

Incyte recognized a one-time $1.23 billion IPR&D expense in Q3 2026 related to its acquisition of Vega Therapeutics.

Source

SEC EDGAROct 29, 2026

Current report (Form 8-K)

Incyte 8-K

Filing excerpt

GAAP and non-GAAP R&D expenses were $1.79 billion and $1.75 billion, an increase of 254% and 274%, respectively, compared to the prior year period, primarily driven by a one-time $1.23 billion IPR&D expense related to the acquisition of Vega Therapeutics.

sec.gov/Archives/edgar/data/879169/000087916926000063/incy-20261029.htmRead the full source

Extracted by Autobound

From the Signal API record
Signal
8-K: Acquisition completed

What this signalsIntegration work after a deal often opens needs for new systems and services.

Form
8-K
Fiscal year end
10/29
Filed
Oct 29, 2026

The full record

From the Signal API record

Numbers

Dollar figure
$1.2B (IPR&D expense related to acquisition of Vega Therapeutics)

Details

CIK
879169
Accession number
0000879169-26-000063
Timeframe
Current quarter
Filing year
2026
Why it matters
Active integration needs
Signal category
Strategic

Extraction

Confidence
High
Relevance
85%
Sentiment
Neutral
Detected
Nov 3, 2026
signal_type
sec-8k
signal_subtype
acquisitionCompleted

Use this data

Get every 8-K signal for Incyte and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Incyte this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/9425abb4-0ab4-4794-8cf1-a132e79145ee returns this record as JSON. POST /v1/companies/enrich returns every signal for incyte.com.

{
  "signal_id": "9425abb4-0ab4-4794-8cf1-a132e79145ee",
  "signal_type": "sec-8k",
  "signal_subtype": "acquisitionCompleted",
  "detected_at": "2026-11-03T07:10:14.671+00:00",
  "company": {
    "name": "Incyte",
    "domain": "incyte.com"
  },
  "data": {
    "detail": "Incyte recognized a one-time $1.23 billion IPR&D expense in Q3 2026 related to its acquisition of Vega Therapeutics. Life sciences IT and clinical development vendors may find integration and late-stage trial support opportunities.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "IPR&D expense related to acquisition of Vega Therapeutics",
      "dollar_millions": 1230
    },
    "summary": "Incyte Recognizes $1.23 Billion IPR&D Expense from Completed Acquisition of Vega Therapeutics",
    "excerpts": "GAAP and non-GAAP R&D expenses were $1.79 billion and $1.75 billion, an increase of 254% and 274%, respectively, compared to the prior year period, primarily driven by a one-time $1.23 billion IPR&D expense related to the acquisition of Vega Therapeutics.",
    "relevance": 0.85,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/879169/000087916926000063/incy-20261029.htm",
    "filing_date": "2026-10-29",
    "filing_year": 2026,
    "fiscal_year_end": "10/29",
    "sales_relevance": "Active integration needs",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.